Novartis Range Of Products Are Popular All Over The World

Medicines contain one of the hottest demands in the world, as they are capable of saving the life of a person. Every person, at some point of time requires some sort of medicines. Some people need to depend on medicines most part of their life if they are suffering from diseases like hypertension and elevated blood pressure.

Innovation in Novartis boosting stock market performance

Novartis is a renowned multinational business that deals in the research and development of products aimed at establishing safe healthcare. It was established in 1996 as a result of the merger of two prestigious companies; Ciba-Geigy and Sandoz. Novartis is present in nearly 140 countries all over the world where it is engaged in numerous activities such as the provision of Vaccines, generics, pharmaceuticals and eye care. It operates with the aim of improvement of life quality over the globe.

In accordance with this aim, Novartis had developed a new Lucentis drug that was intended to enhance eyesight and reduce vision loss. Results have shown that the effects of the drug in reducing eyesight loss can already be seen across many indicators. This success has profoundly soared the company’s popularity. It can also be felt in the stock markets as activity has increased following the proved effectiveness of the medicine, NVS shares rose by 1%. The Swiss stock market was also showing a bullish trend mostly due to the brilliant financial performance exhibited by Novartis and Nestle.

The impact of this development are also apparent in the analysis of NVS stock charts and stock prices. The stock charts have been on the rise following the development. The stock price today is $88.41. It has risen as compared to the same time last year when it was 73.65.  This shows that the higher profitability which accompanied the development of the drug has been welcomed by investors.

Novartis’ Pharmaceuticals Have the Best Stock Rates for year 2012

Novartis is an International company in Basel, Switzerland. It has been ranked as number two among other companies in U.S. industry, in 2010. It is a pharmaceutical company that manufactures drugs as Voltaren and Diovan. In 1996, Sandoz merged with another pharmaceutical company to form Novartis. Its services also provide agrochemical products to its customers. Later, in year 2003, Novartis introduced a new generic product and named it Sandoz Novartis. It is a member of International Federation of Pharmaceutical Association and European Pharmaceutical Association.

Novartis stock is a Hold as for now

Novartis (NVS), a Swiss pharmaceutical company announced recently that it was getting out of the technology due to the challenges with formulation and delivery and due to only a few medical applications that have the potential. Last week, the market saw the Biotech selloff which had resulted in NASDAQ 100 Index down by more than 3%.

Novartis Pharma and expectation in 2014

Novartis Pharmaceuticals is a multinational group of companies, which is in the medicine industry. The company specializes in the research and development, manufacturing and selling of products in pharmaceutical industry.